Overview of U.S. Medical and Recreational Cannabis Legal Landscape
Summary
The passage provides a general summary of state cannabis regulations without mentioning specific individuals, transactions, or misconduct. It lacks actionable leads, novel revelations, or connections Distinguishes profit vs non‑profit rules for medical cannabis cultivators. Lists CBD/limited laws and notable named acts (e.g., Carly’s Law). Chronicles the rollout of recreational cannabis laws from
This document is from the House Oversight Committee Releases.
View Source CollectionTags
Related Documents (6)
Ackrell Capital Cannabis Investment Report predicts federal legalization and market growth
The passage is a market analysis forecasting cannabis legalization and industry trends. It contains no specific allegations, transactions, or names of high‑profile individuals or agencies that would m Predicts removal of cannabis from CSA schedules and full federal legalization. Anticipates rapid market growth driven by interstate commerce and banking access. Notes increasing medical recognition o
Cannabis Industry Company Listings in 2017 Investment Report
The passage lists several small cannabis businesses and a research firm with no mention of high‑profile officials, financial misconduct, or controversial actions. It provides no actionable leads, date Identifies Auntie Dolores, a cannabis edibles producer in Oakland, CA. Lists BAS Research, a cannabis oil extraction and manufacturing firm in Berkeley, CA. Mentions Baker Technologies, a CRM platfor
Cannabis Investment Report – Comparison of U.S. Stock Market Listing Requirements (Dec 2017)
The passage only provides generic data on listing standards for Nasdaq, NYSE, and OTC markets. It contains no references to influential actors, financial flows, misconduct, or investigative leads. Most cannabis‑related public companies trade on the OTC due to looser requirements. Nasdaq and NYSE have higher minimum share prices and stricter governance standards. OTC tiers (OTCQX, OTCQB, OTCPink) v
Cannabis Industry Report Listing Companies and Platforms (Dec 2017)
The passage is a generic industry directory with no mention of influential political actors, financial flows, or misconduct. It provides only company names and URLs, offering no actionable investigati Lists KIVA Confections, LeafLink, Korova, and Leafly as cannabis-related businesses. Includes locations and website URLs for each company. Identifies the document as a Cannabis Investment Report date
Ackrell Capital Cannabis OTC Market Valuation Table (2017)
The document is a financial listing of small OTC cannabis companies with market metrics. It contains no references to influential political figures, government agencies, or alleged misconduct, offerin Provides EV multiples and stock price discounts for over 40 cannabis firms. Compiled by Ackrell Capital, a FINRA/SIPC member. Data dated November 30, 2017.
Directory of Top 100 Private Cannabis Companies (2018) with Company Descriptions
The passage is a simple listing of cannabis businesses and their services, lacking any mention of influential political figures, financial misconduct, or investigative leads. It provides no actionable Lists several cannabis companies and their product offerings. Includes website URLs and locations for each company. Mentions Ackrell Capital, LLC as a FINRA/SIPC member.
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.